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Objectives: To compare cultured microorganisms identiﬁed on endotracheal tubes bioﬁlms
through sonication technique with traditional tracheal aspirate collected at extubation of
pediatric intensive care unit patients.
Methods: Demographic and epidemiological data were analyzed to identify factors possibly
related with the microbiological proﬁle of the two collection methods. Associations between
categorical and continuous variables were analyzed using the chi-square or Fisher’s exact
test, or Student’s t test. p-Value <0.05 were considered signiﬁcant.
Results: Thirty endotracheal tubes and tracheal aspirates samples from 27 subjects were
analyzed. Only one patient presented the clinical diagnosis of ventilator-associated pneu-
monia. Overall, 50% of bacteria were Gram-negative bacilli, followed by Gram-positive
bacteria in 37%, and fungi in 10%. No statistically signiﬁcant difference on the distri-
bution of Gram-positive or Gram-negative bacteria (p = 0.996), and fungi (p = 0.985) were
observed between the collection methods. Pseudomonas spp. was the most frequent microor-
ganism identiﬁed (23.8%), followed by Streptococcus spp. (18.5%), Acinetobacter spp. (15.9%),
coagulase-negative staphylococci (11.2%), and Klebsiella spp. (8.6%). Concordant results
between methods amounted to 83.3%. Pseudomonas aeruginosa and Acinetobacter baumanniishowed carbapenem resistance in 50% and 43.7% of the isolates, respectively. In general, cul-
tures  after endotracheal tubes sonication (non-centrifuged sonication ﬂuid and centrifuged
sonication ﬂuid) yielded bacteria with higher rates of antimicrobial resistance compared
 cultures. Additionally, in 12 subjects (40%), we  observed discrepanciesto  tracheal aspiratesregarding microbiologic proﬁles of cultures performed using the collection methods.
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Conclusions: Our study demonstrated that sonication technique can be applied to ET bioﬁlms
to  identify microorganisms attached to their surface with a great variety of species iden-
tiﬁed.  However, we did not ﬁnd signiﬁcant differences in comparison with the traditional
tracheal aspirate culture approach.
©  2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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pediatric patients. This collected secretion, that otherwisentroduction
osocomial pneumonia represents approximately one quar-
er of all nosocomial infections and tracheal intubation
ncreases the risk for infection by six to 20 times higher.1,2
mong patients under mechanic ventilation on intensive
are unit (ICU), ventilator-associated pneumonia (VAP) rep-
esents the most frequent type of nosocomial infection,
hich extends the length of hospitalization, increase mor-
ality and costs of ICU treatment.1 The clinical diagnosis
f VAP has been based upon local and systemic signs and
ymptoms of infection in addition to radiological criteria.1,2
urthermore, bacteriological diagnosis using protected speci-
en  brush (PSB), bronchoalveolar lavage (BAL), and protected
ndotracheal aspirates have been fully standardized but lack
peciﬁcity, as it relies upon the identiﬁcation of microorgan-
sms growing in tracheal secretion.1–4 Nevertheless, bacteria
rowing in bioﬁlms attached to the endotracheal tube may also
lay a role in the pathogenesis of VAP.5,6 Indeed, the knowl-
dge of bioﬁlm formation by microorganisms in a series of
edical devices and its association to difﬁcult-to-treat infec-
ions has become a concerning in the nosocomial setting.7
herefore, the VAP represents a clear example of multifac-
orial infection in which the bioﬁlm may be implicated not
nly on the pathogenesis, but equally on the high preva-
ence of multiresistant bacteria.8–12 The endotracheal tube
ET) allows direct entry of microorganisms from the orophar-
nx environment into the lower respiratory tract, whereas the
nnate immune system components are ineffective.12–14 Thus,
T allows microorganisms presenting natural ability to form
ioﬁlm to attach on the tube surface through production of a
atrix of polysaccharides and proteins that provides protec-
ion and consequent survival in the environment.10 According
o previous publications, bacteria within the bioﬁlm can infect
he lungs by several ways: through detachment of bioﬁlm por-
ions, thus reaching the lungs and by aspiration into deeper
irways of aerosolized planktonic pathogens detached from
he bioﬁlm.13,14
Recently, microbial diagnosis of implant-associated infec-
ions has been incremented by using vortexing and sonica-
ion technique applied to dislodge sessile microorganisms
ttached to a variety of medical implants, by disrupting the
olymer matrix on the surface of the bioﬁlm while maintain-
ng the integrity of the pathogen.15–17 Trampuz et al., Inacio
t al., and Vandecandelaere et al. were some of the authors
hose studies applied sonication for identifying pathogens
rom bioﬁlms attached to different human implants.15,17–20espite the lack of data, ET sonication may be an interest-
ng tool to increase the yield of detection of sessile pathogens
nd its possible effect on the pathogenesis of VAP.licenses/by-nc-nd/4.0/).
Therefore, we  aimed to compare the yield of cultured
microorganisms collected by ET centrifuged and non-
centrifuged sonication ﬂuid with microorganisms collected by
conventional endotracheal aspiration of intubated pediatric
ICU patients.
Materials  and  methods
Study  population
We  performed a pilot microbiological cross-sectional study
comparing the microbial colonization of ET submitted to
sonication with the microbial yield of cultures of collected tra-
cheal aspirates at the time of elective extubation. A total of
27 pediatric ICU patients under mechanical ventilation, from
December 2012 to June 2014 at the Santa Casa de São Paulo
School of Medicine (Brazil) were evaluated. The collection of
tracheal aspirates was performed prior to extubation as part
of the ICU physiotherapist routine in order to prevent bron-
choaspirations. Subjects were excluded when clinical data
were unavailable for analysis, when no tracheal aspirates were
collected during extubation, or when contamination of ET
occurred during extubation, transportation, or processing in
the microbiology laboratory. As a cross-sectional study, study
participants were not followed-up. The Research Ethics Com-
mittee at our institution approved the project and waiver of
obtaining an informed consent, as the investigators have nei-
ther interfered in patient management nor in the indication
of extubation.
Diagnosis  of  VAP
The diagnosis criteria for VAP were based on the CDC  guide-
lines, in which patients on mechanical ventilation develop
pneumonia 48 h after intubation.21 The diagnostic triad
consisted of clinical evidence of pulmonary infection, includ-
ing fever, purulent secretions, leukocytosis or leukopenia,
signs of respiratory distress and worsening gas exchange;
radiologic suggestion of pulmonary infection, such as persis-
tence of lung inﬁltrate, consolidations and cavitations; and
microbial evidence of pulmonary infection.21
Collection  of  samples  and  sonication  method
Prior to extubation, the ICU physiotherapy team routinely
collects tracheal secretions to prevent bronchoaspiration inwould be discarded, was then used for the microbial analyses
of the study. After extubation, the distal 10 cm of the ET were
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Fig. 1 – Frequency of Gram-positive, Gram-negative and470  b r a z j i n f e c t d 
chopped off and submitted to aseptic cleaning on its surface
with either alcohol 70% or chlorhexidine. The cleaned por-
tions of the ET were stored in a 50 mL  Falcon tubes with the
addition of 20 mL  of sterile NaCl saline solution (0.9%). The
samples were processed and cultivated within 6 h from col-
lection; on the laboratory the Falcon tubes were subjected to
two cycles of vortexing for 30 s using a Vortex-Genie 2 (Sci-
entiﬁc Industries Inc., Bohemia, NY, USA), interspersed by
sonication for 5 min  at a frequency of 40 ± 2 kHz with power
density of 0.22 W/cm2 ±0.04, using the ultrasonic washer
model BactoSonic 14.2 (Bandelin Electronic GmbH & Co. KG,
Germany), according to previous publications.15,17 After the
second vortexing, aliquots of 0.1 mL  of non-centrifuged son-
ication ﬂuid were inoculated on aerobic sheep blood and
chocolate agar plates. The Falcon tube was then submitted
to centrifugation for 5 min  at 2500 rpm, the supernatant aspi-
rated, leaving other aliquot of 0.1 mL  to be plated in the same
media. Along the ET, tracheal secretion samples from the same
patients were collected by the ICU team. The tracheal aspi-
rate samples were also inoculated with a calibrated loop, using
aliquots of 0.1 mL  onto blood and chocolate agar plates, and
then interpreted after overnight incubation in appropriated
conditions.
Microbiological  analysis
Microbial analysis was performed for both centrifuged and
non-centrifuged sonication ﬂuid samples and for tracheal
aspirates. The culture media were incubated for 48 h, both at
a temperature of 35–37 ◦C. The chocolate agar was incubated
in a capnophilic atmosphere. The plates showing micro-
bial growth underwent quantiﬁcation and identiﬁcation of
bacteria according to the routine established by the labora-
tory, considering the morphology and tinctorial properties
displayed on Gram stain. In both methods, approximately
3–4 colony-forming units (CFU) were used as suspensions
in saline until the inoculum reached 0.5 MacFarland scale
(1.5 × 108 CFU/mL). The inoculum was plated in Mueller
Hinton Agar or Mueller Hinton Blood Agar. After 24-h incu-
bation, the diameters of inhibition zones were measured and
interpreted in accordance to standards for tested antimicro-
bial drugs.22 Catalase tests were performed on colonies of
Gram-positive cocci for identifying Staphylococcus spp. and
Streptococcus spp. DNAse tests differentiated Staphylococcus
aureus from coagulase-negative staphylococci, while groups
of Streptococcus spp. and Enterococcus spp. were identiﬁed by
their hemolysis (alpha, beta or gamma), passing to hydrolysis
of bilesculina tests and growth on 6.5% NaCl associated with
susceptibility testing to optochin and bacitracin or CAMP Test,
when necessary. The colonies of Gram-negative bacteria were
identiﬁed by biochemical methods to determine their genus
and species. The CLSI standardized disk diffusion method
was used for all strains in the identiﬁcation of susceptibil-
ity proﬁle, and for vancomycin, we  applied the Etest® (AB
Biodisk, France) for determination of minimum inhibitory
concentration (MIC).23 Antimicrobials used for testing the
cultivated pathogens followed the recommendations of
the CLSI.fungi grown in the three different techniques performed.
Statistical  data
Subject and epidemiological variables and other microbi-
ological ﬁndings were summarized by using frequencies,
percentages, means and standard deviations. Associations
between categorical variables were analyzed using the chi-
square or Fisher’s exact test. Comparison of continuous
variables was performed with the Student’s t test. Differences
were considered signiﬁcant at a p-value <0.05.
Results
Study  population  and  empirical  antimicrobial  therapy
Thirty ET and tracheal aspirates samples were obtained from
27 patients. Three endotracheal tubes and TA samples were
obtained from a single subject at different moments due to
reintubation. The subjects mean age was 3.25 ± 3.93 years,
in which 17 patients (56.6%) were younger than one-year-
old; 63.33% were male. Median length of hospital stay and
time on mechanical ventilation were 16.2 ± 12.76 days and
12.33 ± 8.31 days, respectively. Only one subject presented the
clinical diagnosis of VAP. Table 1 summarizes epidemiologi-
cal data and clinical characteristics of the study population,
such as length of hospital stay, days of mechanical venti-
lation, main reason for ICU admission, empirical antibiotic
therapy. In addition, this table shows the frequencies of pos-
itive cultures according to the collection methods, namely
tracheal aspirates (TA), sonication ﬂuid (SF), and centrifuged
sonication ﬂuid cultures (CSF). There were no signiﬁcant dif-
ferences in the frequency of positive cultures according to the
collection methods, after adjusting for epidemiological data,
clinical characteristics, and type of empirical antibiotic ther-
apy (Table 1).
Microbiology  of  centrifuged,  non-centrifuged  sonication
ﬂuids  and  tracheal  aspirate  cultures
In general, up to 50% of identiﬁed microorganisms were
Gram-negative bacilli,  followed by Gram-positive bacteria
in 37%, whereas fungi represented less than 10% (Fig. 1).
No statistically signiﬁcant differences on the distribution
of Gram-positive or negative bacteria (p = 0.99), and fungi
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Table 1 – Epidemiological data and prescribed antibiotics of study subjects and comparison with the frequency of
positive cultures in each microbiological technique.
Hospitalization data Subjects
N = 30
Positive cultures p-Valueb
TAa SFa CSFa
Length of hospitalization
0–5 days 3 (10%) 1 (33.3%) 2 (66.6%) 1 (33.3%) 0.78
6–10 days 9 (30%) 9 (100%) 8 (88.8%) 9 (100%) 0.96
11–15 days 7 (23.3%) 7 (100%) 6 (85.7%) 4 (57.14%) 0.66
16–20 days 3 (10%) 3 (100%) 3 (100%) 3 (100%) –
20+ days 8 (26.6%) 8 (100%) 8 (100%) 8 (100%) –
Length of intubation
0–5 days 8 (26.6%) 6 (75%) 7 (87.5%) 6 (75%) 0.95
6–10 days 7 (23.3%) 7 (100%) 6 (85.7%) 6 (85.7%) 0.95
11–15 days 6 (20%) 6 (100%) 5 (83.3%) 3 (50%) 0.6
16–20 days 3 (10%) 3 (100%) 3 (100%) 3 (100%) –
20+ days 6 (20%) 6 (100%) 6 (100%) 6 (100%) –
Reasons of hospitalization
Acute respiratory failure
(bronchopneumonia, bronchiolitis)
12  (40%) 10 (83.3%) 11 (91.6%) 9 (75%) 0.9
Acute respiratory failure (VAP) 1 (3.3%) 1 (100%) 0 0 0.36
Meningitis 2 (6.6%) 2 (100%) 2 (100%) 2 (100%) –
Septic shock 6 (20%) 6 (100%) 5 (83.3%) 6 (100%) 0.94
Non-infectious diseases
(Trauma, GI diseases, congenital disorders)
9  (30%) 8 (88.8%) 8 (88.8%) 7 (77.7%) 0.95
Hospitalization data Subjects
N = 27
Positive cultures p-Valueb
TAa SFa CSFa
Antibiotics prescribed
Ceftazidime 1 (3.70%) 1 (100%) 1 (100%) 1 (100%) –
Amikacin 4 (14.81%) 4 (100%) 4 (100%) 4 (100%) –
Metronidazole 3 (11.11%) 3 (100%) 2 (66.6%) 3 (100%) 0.88
Ceftriaxone 15 (55.55%) 14 (93.3%) 14 (93.3%) 12 (80%) 0.90
Clindamycin 4 (14.81%) 4 (100%) 3 (75%) 4 (100%) 0.91
Vancomycin 15 (55.55%) 15 (100%) 14 (93.3%) 13 (86.6%) 0.93
Meropenem 15 (55.55%) 15 (100%) 14 (93.3%) 13 (86.6%) 0.93
Fluconazole 8 (29.62%) 8 (100%) 7 (87.5%) 7 (87.5%) 0.95
Cefazolin 2 (7.40%) 1 (50%) 1 (50%) 1 (50%) –
Micafungin 2 (7.40%) 2 (100%) 2 (100%) 2 (100%) –
Cefepime 3 (11.11%) 3 (100%) 2 (66.6%) 3 (100%) 0.88
Oxacillin 13 (48.14%) 12 (92.3%) 11 (84.6%) 10 (77%) 0.91
Piperacillin/tazobactam 2 (7.40%) 2 (100%) 2 (100%) 2 (100%) –
Crystalline penicillin 3 (11.11%) 3 (100%) 3 (100%) 3 (100%) –
Clarithromycin 2 (7.40%) 2 (100%) 2 (100%) 2 (100%) –
Amphotericin B 1 (3.70%) 1 (100%) 1 (100%) 1 (100%) –
Ampicillin/sulbactam 1 (3.70%) 1 (100%) 1 (100%) 1 (100%) –
Azithromycin 1 (3.70%) 1 (100%) 1 (100%) 1 (100%) –
TA, tracheal aspirate; SC, non-centrifuged sonication ﬂuid; CSF, centrifuged sonication ﬂuid.
a Hospitalization data were summarized as frequencies and percentages or median and compared using the chi-square or Fisher’s exact test
as appropriate to categorical variables and t-test as appropriate to continuous variables. All tests were two sided and p-values less than 0.05
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b Medication frequency was calculated based on 27 samples, since in
p = 0.98) according to the collection three methods. Pseu-
omonas spp. (23.8%) and Streptococcus spp. (18.5%) were the
ost frequently identiﬁed pathogens, followed by Acineto-
acter spp. (15.9%), coagulase-negative staphylococci (11.2%),
lebsiella spp. (8.6%) and Staphylococcus aureus (4.6%). Inter-
stingly, there was no statistically signiﬁcant difference on
he distribution of microorganisms isolated from sonica-
ion ﬂuid (centrifuged and non-centrifuged) compared with
racheal aspirate. Table 2 summarizes the frequencies ofe of them the data was unavailable.
microorganisms cultured according to the collection method
ET submitted to sonication and the method of conventional
tracheal aspirate.
Discordant  and  discrepant  culture  results  to  TA,  SF  and
CSF  collection  methods
In all but one ET and TA samples no microbial growth was
detected neither on SF, CSF nor on TA cultures (3.3%, 1/30). The
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Table 2 – Distribution of species of bacteria and fungi according to its frequencies in cultures of tracheal aspirates,
sonication ﬂuid, and centrifuged sonication ﬂuid.
Microorganisms (N = 151) TA
(N = 53)
SF
(N  = 48)
CSF
(N  = 50)
p-Valuea
Pseudomonas spp. 23.8% (36/151) 24.52% (13/53) 22.91% (11/48) 24% (12/50) 0.98
Streptococcus spp. 18.5% (28/151) 20.75% (11/53) 18.75% (9/48) 16% (8/50) 0.90
Acinetobacter spp. 15.9% (24/151) 13.2% (7/53) 16.66% (8/48) 18% (9/50) 0.80
CNSb 11.2% (17/151) 9.43% (5/53) 10.41% (5/48) 14% (7/50) 0.75
Klebsiela spp. 8.6% (13/151) 9.43% (5/53) 8.33% (4/48) 8% (4/50) 0.98
Candida spp. 7.3% (11/151) 7.54% (4/53) 6.25% (3/48) 8% (4/50) 0.94
S. aureusc 4.6% (7/151) 5.66% (3/53) 4.16% (2/48) 4% (2/50) 0.92
Chromobacterium spp. 2% (3/151) 1.88% (1/53) 2.08% (1/48) 2% (1/50) 0.99
Enterococccus spp. 2% (3/151) 0 4.16% (2/48) 2% (1/50) 0.33
Enterobacter spp. 2% (3/151) 1.88% (1/53) 2.08% (1/48) 2% (1/50) 0.99
Neisseria spp. 2% (3/151) 1.88% (1/53) 2.08% (1/48) 2% (1/50) 0.99
C. indologenesd 0.66% (1/151) 0 2.08% (1/48) 0 0.34
Escherichia coli 0.66% (1/151) 1.88% (1/53) 0 0 0.41
Rhodotorola rubra 0.66% (1/151) 1.88% (1/53) 0 0 0.41
TA, tracheal aspirate; SC, non-centrifuged sonication ﬂuid; CSF, centrifuged sonication ﬂuid.
a Microbiologic results were summarized as frequencies and percentages and also compared using the chi-square or Fisher’s exact test as
appropriate to categorical variables. All tests were two sided and p-values less than 0.05 were considered statistically signiﬁcant.
b Coagulase-negative staphylococci.
c Staphylococcus aureus.
d Chryseobacterium indologenes.global concordance (positive and negative results) between TA,
SF, and CSF was 83.3%. There were ﬁve discordant results, in
which only one subject had sonication ﬂuid culture-positive
and TA culture-negative result. On the other hand, the only
subject showing clinical diagnosis of VAP had TA culture-
positive (Escherichia coli) and SF/CSF culture-negative results.
Surprisingly, subject #11 was not clinically diagnosed with
VAP, but TA cultures yielded Pseudomonas spp., Klebsiella spp.,
S. aureus,  and only Klebsiella spp. on SF cultures. Two subjects
presented CSF culture-negative results, but cultures of SF and
TA were positive and discrepancy was detected in one of them
(Table 3). Additionally, we  found microbiological discrepancies
(positive cultures on TA, SF, and CSF, but different microbio-
logical proﬁles) among 12 (40%) subjects. Table 3 summarizes
the discrepant and discordant results between TA, SF, and CSF
cultures.
Regarding antimicrobial resistance, there were different
patterns of susceptibility to antimicrobials among the same
microorganisms identiﬁed on TA, SF, and SCF cultures. Of
interest, Pseudomonas aeruginosa and Acinetobacter baumannii
showed carbapenem resistance in 50% and 43.7% of the iso-
lates, respectively. In general, cultures after ET sonication
(SF and CSF) yielded bacteria with higher rates of antimi-
crobial resistance compared to TA cultures. For example,
carbapenem-resistant and cefepime-resistant P. aeruginosa
isolated from SF, CSF, and TA cultures were 35%, 35%, 29%,
and 37.5%, 37.5%, 25%, respectively. Carbapenem-resistant A.
baumannii isolated from SF, CSF, and TA cultures were 28.5%,
42.8%, 28.5%, respectively. Methicillin-resistant S. aureus
(MRSA) was identiﬁed in 28.5% of the isolates, and Klebsiella
pneumoniae Carbapenemase (KPC) was isolated in only one
subject, identiﬁed in TA, SF, and SCF cultures.Discussion
Microbiological data showing ET bioﬁlm ﬂora and upper air-
way colonization remains insufﬁcient, even though it has
been frequently recognized as potential risk factors for
nosocomial pneumonia. Therefore, we aimed to provide infor-
mation regarding the microbiota attached to ET inner surfaces
bioﬁlms by use of sonication and compared to conventional
tracheal aspirates cultures, among colonized pediatric ICU
patients. Sonication has been frequently applied for dis-
lodging bioﬁlm sessile pathogens, and therefore validated
as an adds-on technique for microbial diagnosis of different
human device-associated infection.15–17,19 Vandecandelaere
et al. applied sonication on ET for bioﬁlm detachment and
compared with TA surveillance cultures among mechani-
cal ventilated adult patients, and found correlation between
antibiotic-resistant pathogens identiﬁed either on ET bioﬁlms
and tracheal secretion cultures.20 Gil-Perotin et al. analyzed
the formation of ET bioﬁlm and its implication to VAP by
scraping the bioﬁlm from the inner surface of ET followed by
vortexing. Bioﬁlm was found almost universally on ET and
50% of bacteria associated to VAP were also cultured from
bioﬁlms.11
To our knowledge, no previous studies have applied son-
ication and vortexing on ET for bioﬁlm microbial analysis
in the ICU pediatric population. Unlike others authors, we
investigated microbial bioﬁlm formation on ET mainly among
subjects with no clinical diagnosis of VAP (with one excep-
tion), even though they were all on systemic antimicrobial
therapy for varied reasons. We found that even on colonized
mechanically ventilated pediatric patients, there were a high
prevalence (96.7%) of ET bioﬁlm formation after intubation.
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Table 3 – Subjects with discordant and discrepanta culture results of tracheal aspirates, sonication ﬂuid, and centrifuged
sonication ﬂuid.
Samples VAP TA SF CSF
1 N Klebsiella spp. Klebsiella spp., CNSb, Acinetobacter spp. Klebsiella spp., Enterococcus spp.
2 N Streptococcus spp.
Rhodotorula rubra, Candida spp.
Streptococcus spp., CNSc Negative
3 N Acinetobacter spp.
Pseudomonas spp.
Acinetobacter spp. Acinetobacter spp.,
Pseudomonas spp.
CNSb
4 N Streptococcus spp.,
Candida spp.
Acinetobacter spp.
Streptococcus spp.,
S. aureusc
Streptococcus spp.,
Candida spp., CNSc
6 N Streptococcus spp.,
CNSb
Streptococcus spp. Streptococcus spp.,
CNSb
7 N Pseudomonas spp. Streptococcus spp.,
Pseudomonas spp.
CNSb
8 N Pseudomonas spp.,
Candida spp.
Streptococcus spp.,
Pseudomonas spp.,
Candida spp.
Streptococcus spp.,
Pseudomonas spp.,
Candida spp., S. aureusc
9 N Streptococcus spp.,
S. aureusc
Klebsiella spp. Klebsiella spp.
10 N Negative Streptococcus spp. Negative
11 N Peusdomonas spp.,
Klebsiella spp.,
S. aureusc
Klebsiella spp. Negative
14 N Acinetobacter spp.
Klebsiella spp.
Acinetobacter spp.,
Candida spp.
Acinetobacter spp.,
Candida spp.
17 N Streptococcus spp. Pseudomonas spp. Pseudomonas spp.
18 N Pseudomonas spp.,
CNSb
Pseudomonas spp.
CNSb, C. indologenesd
Pseudomonas spp.
19 Y Streptococcus spp.,
CNSb, E. coli
Negative Negative
20 N Streptococcus spp.,
Candida spp.
Streptococcus spp.,
Candida spp.
Acinetobacter spp.,
Enterococcus spp.
Streptococcus spp.,
Candida spp.
Acinetobacter spp.
23 N Streptococcus spp.,
Klebsiella spp.
Klebsiella spp.,
Enterococcus spp.
Acinetobacter spp.,
Klebsiella spp.,
Streptococcus spp.
28 N Pseudomonas spp. Pseudomonas spp. Negative
VAP, ventilator-associated pneumonia; TA, tracheal aspirate; SC, non-centrifuged sonication ﬂuid; CSF, centrifuged sonication ﬂuid.
a Discordance: the absence of pathogens in any techniques used to evaluate one patient samples. Discrepancy: the presence of different
pathogens among one patient’s sample when collected by different techniques.
b Coagulase-negative staphylococci.
c Staphylococcus aureus.
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revious authors have already acknowledged the association
etween upper respiratory tract colonization, microaspiration,
nd bioﬁlm formation on the surface of ET as risk factor for
osocomial pneumonia.5,6,8,9,11 Another important aspect of
ur study was the special attention to investigate the micro-
ial results of SF using a concentration step. Indeed, many
uthors have added a SF concentration step using samples
entrifugation to identify higher number of microorganisms
n the sample.15–19,24 At least for bioﬁlms attached to ET inner
urface, centrifugation of sonication ﬂuid was not statistically
uperior to non-centrifuged SF to increase microbial diagno-
is.Along with other results,5,11 in this study TA and SF cul-
ures yielded mostly Gram-negative bacilli, mainly P. aeruginosa
nd A. baumannii (40%). These pathogens have been highlyassociated with severe acute and chronic nosocomial respi-
ratory infections as they are easily capable of expressing
bioﬁlm-forming and antibiotic-resistant genes.1,5–11,20,25,26
Previous studies analyzed the microorganisms present in den-
tal plaque of ICU patients and showed that more  isolates
of P. aeruginosa were identiﬁed when compared to the gen-
eral population.27–28 Besides, Pseudomonas spp., although not a
common inhabitant of oral microﬂora is an important respira-
tory pathogen frequently associated with late-onset VAP.7,11,27
The remarkable ability of P. aeruginosa to adhere and form
complexes bioﬁlm structures in sputum, lung tissues, and ET
and therefore producing difﬁcult-to-treat chronic infections,
such as cystic ﬁbrosis and VAP, was the very beginning of
studies connecting bioﬁlm science with medicine.5,13,14 Broad-
spectrum antimicrobial therapy was offered for all patients
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in our studied sample, which might have contributed to the
high prevalence of A. baumannii isolated. Indeed, late-onset
VAP have been frequently caused by multidrug-resistant A.
baumannii,  an environmental opportunistic bioﬁlm-forming
low-virulent pathogen capable of surviving to moist and dry
conditions for a prolonged period, and associated to previous
use of systemic empirical antibiotics.25,26,29,30 Of note, com-
mon oral microbiota such as Streptococcus spp., which presents
a wide variety of species, including S. mutans, a bioﬁlm pro-
moter, were also frequently isolated.27 Coagulase-negative
staphylococci, which have a well-known genetic predispo-
sition to form bioﬁlms, were also frequently detected on
cultures. Our results seemed to be in accordance with a recent
study that applied traditional culture methods and molecular
techniques to assess the microbial diversity of ET bioﬁlms,
and eventually identiﬁed coagulase-negative staphylococci,
mainly S. epidermidis as the most frequently encountered
organism on cultures.18
In our study, the overall microbial culture results observed
from each collection technique were concordant (83%), which
suggests that culture of all three techniques (TA, SF, and CSF)
may have isolated both sessile and planktonic cells. A study by
Vandecandelaere et al. also suggests an agreement of results
between surveillance cultures and ET bioﬁlm cultures using
sonication technique.20 However, in a situation of VAP, accord-
ing to ESCMID guideline for the diagnosis and treatment of
bioﬁlm infections, it is difﬁcult to determine if the bioﬁlm
within the ET can be either the primary source of infection or
merely a concomitant colonized site.6 Also, respiratory secret-
ions can accumulate in the ET leading to a vast concentration
of planktonic pathogens in airway secretion, underestimating
the presence of sessile pathogens.
Regarding the presence of discordant results among rein-
tubated patients and discrepancy in antibiotics susceptibility,
biological variation and change of microbial ﬂora due to a
longer stay in ICU might be the reason behind the discord-
ance, once common in-hospital pathogens were found at the
second moment, like Acinetobacter spp., P. aeruginosa and Can-
dida albicans. We  also hypothesize that planktonic forms are
more  susceptible to create drug-resistant strains and are eas-
ily detectable through aspirate cultures. Besides, the bioﬁlm
itself represents a resistance mechanism to antibiotics, and
once the bacteria are dispersed they are detected and rapidly
become susceptible to antibiotics. As no signiﬁcant differ-
ences were found between the techniques assessed in this
study, the tracheal aspirate could be an option for the iden-
tiﬁcation of pathogens from the bioﬁlm, in which was found
a similar microbial sessile ﬂora when compared to the iso-
lates of planktonic pathogens. This study, however, had a
small sample size, which limited the microbiological ﬁndings,
and the strength of our statistical analysis. The absence of
more patients diagnosed with VAP could also underestimate
the ﬁndings by showing less pathogens, as different sensibil-
ity patterns in comparison to the results obtained. Although
our study demonstrated 83.3% of concordance between tech-
niques we  do not recommend using sonication as a diagnostic
test without further studies, which should be performed to
better understand the relation between VAP pathogenesis and
ET bioﬁlms.
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